Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04358822
Collaborator
(none)
68
1
2
2.3
29.6

Study Details

Study Description

Brief Summary

The sequence of events at the time of delivery includes delivery of the infant, clamping of the umbilical cord, and lastly delivery of the placenta. There are some benefits for delayed cord clamping. This study aims to compare the effects of two different duration of delayed cord clamping.

Infants will be randomized into two groups based on the duration of delayed cord clamping: 30 seconds vs 120 seconds. Different hemodynamic effects will be measured in each group at different time intervals. The hypothesis of the study is that delayed cord clamping for 120 seconds is associated with better cardiac output and with other hemodynamic advantages.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Delayed cord clamping
N/A

Detailed Description

The study will include full term infants delivered via cesarean section. Written informed consent for participation in the study will be obtained from parents prior to delivery. Newborns will be randomly assigned into two groups according to the duration of cord clamping: Group 1: the cord will be clamped at 30 seconds, and Group 2: the cord will be clamped at 120 seconds of life. Stopwatch will be started when infants buttocks (or head if breech) are delivered from the uterus. The time elapsed will be counted aloud by the investigator in 10-second intervals. During this time, the infant will be held in linen on the mothers legs. Care will be taken not to apply traction on the cord. Milking of the cord will not be allowed. Immediately after resuscitation, infants will be attached to the leads of the electrical cardiometry device. Device output will be imported at 5, 10, and 15 minutes after birth in both groups. A follow up measurement will be imported later at 24 hours of age. In addition, a peripheral blood sample will be obtained at 24 hours of age for assessment of hemoglobin, glucose and bilirubin concentrations. .

The calculated sample size is 31 newborns in each group. This number will be adequate to detect an effect size of 10% in the mean cardiac output between the two groups with 95% confidence and 80% power. The study plans to recruit 34 infants in each group (10% attrition rate).

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns
Actual Study Start Date :
Jan 21, 2020
Actual Primary Completion Date :
Mar 31, 2020
Actual Study Completion Date :
Mar 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 30 second cord clamping

Infants in this group will receive delayed cord clamping for 30 seconds.

Procedure: Delayed cord clamping
The umbilical cord will be clamped after specific time intervals

Active Comparator: 120 second cord clamping

Infants in this group will receive delayed cord clamping for 120 seconds.

Procedure: Delayed cord clamping
The umbilical cord will be clamped after specific time intervals

Outcome Measures

Primary Outcome Measures

  1. Cardiac output [at 15 minutes]

    Data imported from the electrical cardiometry device

  2. Stroke volume [at 15 minutes]

    Data imported from the electrical cardiometry device

  3. Cardiac index [at 15 minutes]

    Data imported from the electrical cardiometry device

  4. Index of contractility [at 15 minutes]

    Data imported from the electrical cardiometry device

  5. Heart rate [at 15 minutes]

    Data imported from the electrical cardiometry device

  6. Oxygen saturation [at 15 minutes]

    Data imported from the electrical cardiometry device

Secondary Outcome Measures

  1. Hemoglobin concentration [At 24 hours]

    Blood sample will be obtained an analyzed

  2. Serum glucose concentration [At 24 hours]

    Blood sample will be obtained an analyzed

  3. Serum bilirubin concentration [At 24 hours]

    Blood sample will be obtained an analyzed

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Normal full term newborns ≥37 weeks gestational age

  • Both genders are included

  • Singleton

  • Delivered by elective cesarean section due to previous cesarean section, cephalo-pelvic disproportion, or mal-presentation

  • Successfully transitioned without need for respiratory or medication support

Exclusion Criteria:
  • Neonates needing any active resuscitation

  • In-utero fetal distress

  • Suspected perinatal asphyxia

  • Major congenital malformations

  • Twin or multiple gestation

  • Intrauterine growth restriction

  • Placenta previa

  • Mothers with cardiac disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo University Children's Hospital Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Reem Mahmoud, Cairo University Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Reem Mahmoud, Associate Professor of Pediatrics, Cairo University
ClinicalTrials.gov Identifier:
NCT04358822
Other Study ID Numbers:
  • MS-305-2019
First Posted:
Apr 24, 2020
Last Update Posted:
Apr 24, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 24, 2020